
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
08/31/2025 | Q3 | $786.1M | -- | -- | $3.73 | -- |
07/23/2025 | Q2 | $903.1M | -- | -- | $6.28 | -- |
04/08/2025 | Q1 | $1.4B | $1.4B | $10.38 | $10.75 | -$0.37 |
01/07/2025 | Q4 | $751.5M | $954.7M | $4.47 | $4.25 | $0.22 |
10/01/2024 | Q3 | $704.7M | $785.9M | $3.06 | -- | -- |
07/23/2024 | Q2 | $652.3M | $640.8M | $2.32 | -- | -- |
03/19/2024 | Q1 | $692.4M | $703.1M | $3.00 | $2.88 | $0.12 |
01/03/2024 | Q4 | -- | -- | $0.35 | $0.91 | -$0.56 |
10/03/2023 | Q3 | -- | -- | $0.02 | $0.73 | -$0.71 |
07/25/2023 | Q2 | -- | -- | $2.27 | $2.12 | $0.15 |
03/28/2023 | Q1 | -- | -- | $6.62 | $6.34 | $0.28 |
12/28/2022 | Q4 | -- | -- | $4.07 | $4.18 | -$0.11 |
09/27/2022 | Q3 | -- | -- | $2.57 | $1.85 | $0.72 |
07/19/2022 | Q2 | -- | -- | $2.26 | $1.96 | $0.30 |
03/29/2022 | Q1 | -- | -- | $0.81 | $0.87 | -$0.06 |
12/28/2021 | Q4 | -- | -- | $0.02 | $0.10 | -$0.08 |
09/28/2021 | Q3 | -- | -- | -$0.37 | -$0.82 | $0.45 |
07/19/2021 | Q2 | -- | -- | -$0.09 | -$0.18 | $0.09 |
03/29/2021 | Q1 | -- | -- | $0.28 | $0.09 | $0.20 |
01/05/2021 | Q4 | -- | -- | $0.25 | -$0.12 | $0.37 |
09/28/2020 | Q3 | -- | -- | -$0.40 | -$0.59 | $0.19 |
07/20/2020 | Q2 | -- | -- | $1.24 | $1.41 | -$0.17 |
03/30/2020 | Q1 | -- | -- | $0.28 | $0.28 | -$0.00 |
01/06/2020 | Q4 | -- | -- | -$0.21 | $0.08 | -$0.29 |
08/31/2019 | Q3 | -- | -- | -$0.94 | -$0.93 | -$0.01 |
07/22/2019 | Q2 | -- | -- | -$0.41 | -$0.28 | -$0.13 |
04/01/2019 | Q1 | -- | -- | $0.82 | -- | -- |
01/04/2019 | Q4 | -- | -- | $0.45 | -- | -- |
10/01/2018 | Q3 | -- | -- | $0.26 | -- | -- |
07/23/2018 | Q2 | -- | -- | $1.48 | -- | -- |
04/02/2018 | Q1 | -- | -- | $1.99 | -- | -- |
01/05/2018 | Q4 | -- | -- | -$0.54 | -- | -- |
10/02/2017 | Q3 | -- | -- | -$0.33 | -- | -- |
07/24/2017 | Q2 | -- | -- | -$0.51 | -- | -- |
03/27/2017 | Q1 | -- | -- | $0.09 | -- | -- |
12/22/2016 | Q4 | -- | -- | -$0.48 | -- | -- |
09/26/2016 | Q3 | -- | -- | -$0.64 | -- | -- |
07/18/2016 | Q2 | -- | -- | -$0.01 | -- | -- |
03/28/2016 | Q1 | -- | -- | $1.33 | -- | -- |
12/23/2015 | Q4 | -- | -- | $2.26 | -- | -- |
09/28/2015 | Q3 | -- | -- | $2.95 | -- | -- |
Cal-Maine Foods reported $1.4B worth of top line sales in its most recent quarter.
Cal-Maine Foods announced earnings per share of $10.38 which represents a miss of analyst forecast a $10.75 per share.
Cal-Maine Foods reported $716.1M that represents $14.62 per share over the last quarter.
Cal-Maine Foods's earnings are forecast to grow from $5.69 per share to $24.20 per share next year representing an increase of 307.82%.
Cal-Maine Foods's next earnings date is July 23, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.